T-type channels in neuropathic pain - Villain or victim?
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
32167006
PubMed Central
PMC7153802
DOI
10.1080/19336950.2020.1740487
Knihovny.cz E-zdroje
- Klíčová slova
- Pain, T-type channel, calcium channel, glycosylation, phosphorylation, post-translational modifications, sumoylation, ubiquitinylation,
- MeSH
- biologické modely MeSH
- lidé MeSH
- neuralgie metabolismus MeSH
- spinální ganglia metabolismus MeSH
- vápníkové kanály - typ T metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- vápníkové kanály - typ T MeSH
Zobrazit více v PubMed
Bourinet E. Francois A and Laffray S. T-type calcium channels in neuropathic pain. Pain. 2016;157:S15–22. PubMed
Waxman SG, Zamponi GW. Regulating excitability of peripheral afferents: emerging ion channel targets. Nat Neurosci. 2014;17:153–163. PubMed
García-Caballero A, Gadotti VM, Stemkowski P, et al. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron. 2014;83:1144–1158. PubMed
Garcia-Caballero A, Zhang FX, Chen L, et al. SUMOylation regulates USP5-Cav3.2 calcium channel interactions. Mol Brain. 2019;12:73. PubMed PMC
Weiss N, Black SA, Bladen C, et al. Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation. Pflugers Arch. 2013;465:1159–1170. PubMed
Lazniewska J, Rzhepetskyy Y, Zhang FX, et al. Cooperative roles of glucose and asparagine-linked glycosylation in T-type calcium channel expression. Pflugers Arch. 2016;468:1837–1851. PubMed
Ondacova K, Karmazinova M, Lazniewska J, et al. Modulation of Cav3.2 T-type calcium channel permeability by asparagine-linked glycosylation. Channels (Austin). 2016;10:175–184. PubMed PMC
Orestes P, Osuru HP, McIntire WE, et al. Reversal of neuropathic pain in diabetes by targeting glycosylation of Ca(V)3.2 T-type calcium channels. Diabetes. 2013;62:3828–3838. PubMed PMC
Gomez K, Calderón-Rivera A, Sandoval A, et al. Cdk5-dependent phosphorylation of Cav3.2 T-type channels: possible role in nerve ligation-induced neuropathic allodynia and the compound action potential in primary afferent C-fibers. J Neurosci. 2020;2:283–296. PubMed PMC
Snutch TP, Zamponi GW. Recent advances in the development of T-type calcium channel blockers for pain intervention. Br J Pharmacol. 2018;2375–2383. DOI:10.1111/bph.13906 PubMed DOI PMC
